Efficacy of Acupuncture in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Chunyan Yang,Hao Tian,Guixing Xu,Qin Luo,Mingsheng Sun,Fanrong Liang
DOI: https://doi.org/10.2147/copd.s450257
2024-03-12
International Journal of COPD
Abstract:Chunyan Yang, &ast Hao Tian, &ast Guixing Xu, Qin Luo, Mingsheng Sun, Fanrong Liang Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fanrong Liang, Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, No. 37 Shi'er Qiao Road, Chengdu, Sichuan, 610075, People's Republic of China, Email Purpose: The effect of acupuncture as adjunctive therapy for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) was controversial. Thus, we aimed to evaluate the effects of acupuncture for treating AECOPD. Methods: Eight databases were searched from database inception to July 30, 2023. All RCTs compared acupuncture plus conventional western medicine with conventional western medicine alone were included. Outcomes were quality of life, lung function, blood oxygen condition, exercise capacity, daily symptoms, duration of hospitalization, and adverse events. The statistical analyses were conducted using Stata 17.0, and methodological quality was measured by the Cochrane bias risk assessment tool. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to assess the quality of evidence. Results: Twelve studies including 915 patients were included. Compared with conventional western medicine alone, acupuncture combined with conventional western therapy significantly improved quality of life (CAT: MD: − 3.25; 95% CI: − 3.73 to − 2.78, P < 0.001) and arterial blood gas (PaCO 2 : MD: − 1.85; 95% CI: − 2.74 to − 0.95, P < 0.001; PaO 2 : MD: 5.15; 95% CI: 1.22 to 9.07, P = 0.01). And for lung function, statistical benefits were found in FEV 1 /FVC (MD: 4.66; 95% CI: 2.21 to 7.12, P < 0.001), but no difference was seen for FEV 1 % (MD: 1.83; 95% CI: − 0.17 to 3.83, P = 0.073). There was no significant improvement in exercise capacity (6MWD: MD: 96.69; 95% CI: − 0.60 to 193.98, P = 0.051), hospitalization duration (MD: − 5.70; 95% CI: − 11.97 to 0.58, P = 0.075), and dyspnea (mMRC: MD: − 0.19; 95% CI: − 0.61 to 0.63, P = 0.376) between two groups. Overall bias for CAT and mMRC was in "high" risk, FEV1%, FEV 1 /FVC, PaCO 2 , and PaO 2 was in "some concern" and 1 RCT assessing hospitalization duration was in "low" risk. And the overall assessments were either moderate, low or very low certainty. Seven trials performed safety assessment of acupuncture, and no serious adverse events were reported. Conclusion: Acupuncture might have auxiliary effects on AECOPD. However, the quality of the evidence is limited, and more high-quality RCTs are needed to be performed in the future. Keywords: acute exacerbation of chronic obstructive pulmonary disease, acupuncture, systematic review, meta-analysis Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is defined as an acute worsening of respiratory symptoms, such as cough, dyspnea, and increased sputum purulence and volume, which results in additional therapy or even hospitalization. 1,2 AECOPD severely affects lung function and health-related quality of life and has a poor long-term prognosis and increased risk of death after hospitalization, with a 5-year mortality rate of approximately 50%. 3,4 In addition, exacerbations burden patients, caregivers, and their families. 5 It is reported that acute exacerbations can be found 0.5–3.5 times for patients with stable COPD annually, 6,7 and the average hospitalization cost for a person per year may be as high as 11,598 RMB. 8 AECOPD is responsible for up to 70% of COPD-related healthcare costs, and hospital readmissions alone account for over $15 billion per year in the US. 1,9 In the past 20 years, no substantial progress has been made in the treatment of AECOPD 10 and still focuses on bronchodilators, anti-inflammatory drugs, and glucocorticoids. 1,11 These drugs are effective, but they cannot completely cure some symptoms in AECOPD patients. 1 Therefore, reasonable and effective complementary treatments are still needed to better manage AECOPD symptoms. Acupuncture, as a kind of complementary and alternative therapy, has been proven to be effective in anti-inflammatory, immune regulation and enhancing the strength of diaphragm. 12,13 The findings of past systematic reviews and meta-analyses have proved that acupuncture can effectively enhance lung function, quality of life, exercise performance, and dyspnea of COPD patients in stable ph -Abstract Truncated-
respiratory system